2-(4-chloro-3-methoxyanilino)-N-(6H-pyrazolo[3,4-g][1,3]benzothiazol-2-yl)acetamide | 1000372-13-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-(4-chloro-3-methoxyanilino)-N-(6H-pyrazolo[3,4-g][1,3]benzothiazol-2-yl)acetamide
• CAS: 1000372-13-3
• 化学式: C₁₇H₁₄ClN₅O₂S
• 分子量: 387.849
• InChiKey: BTCQZFBDLCTJNW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  26
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  120
• 氢给体数：
  3
• 氢受体数：
  6

文献信息

• ALPHA-AMINO ACID DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME AS AN ACTIVE INGREDIENT
  申请人：Ohrai Kazuhiko

  公开号：US20090275623A1

  公开（公告）日：2009-11-05

  The present invention provides novel α-amino acid derivatives of formula (1): (wherein, R 1 , R 2 , R 3 , R 4 , X and Y are as defined in the claims) or pharmaceutically acceptable salts, prodrugs or solvates thereof. The derivatives of formula (1) have βARK1 inhibitory activity and are useful for preventing or treating heart failure. Moreover, the derivatives of formula (1) also have antitumor activity, particularly dual inhibitory activity on Aurora kinase and CDK, and are useful for cell proliferative diseases such as cancer.

  本发明提供了一种新型的α-氨基酸衍生物，其化学式为(1):(其中，R1、R2、R3、R4、X和Y如权利要求所定义)，或其药学上可接受的盐、前药或溶剂化物。式(1)衍生物具有βARK1抑制活性，可用于预防或治疗心力衰竭。此外，式(1)衍生物还具有抗肿瘤活性，特别是对极化酶和CDK的双重抑制活性，并且可用于细胞增殖性疾病，如癌症。
• a-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT
  申请人：Nissan Chemical Industries, Ltd.

  公开号：EP2045253A1

  公开（公告）日：2009-04-08

  The present invention provides novel α-amino acid derivatives of formula (1): (wherein, R1, R2, R3, R4, X and Y are as defined in the claims) or pharmaceutically acceptable salts, prodrugs or solvates thereof. The derivatives of formula (1) have βARK1 inhibitory activity and are useful for preventing or treating heart failure. Moreover, the derivatives of formula (1) also have antitumor activity, particularly dual inhibitory activity on Aurora kinase and CDK, and are useful for cell proliferative diseases such as cancer.

  本发明提供了式 (1) 的新型 α-氨基酸衍生物： (其中，R1、R2、R3、R4、X 和 Y 如权利要求中定义）或其药学上可接受的盐、原药或溶液。式（1）的衍生物具有 βARK1 抑制活性，可用于预防或治疗心力衰竭。此外，式（1）的衍生物还具有抗肿瘤活性，特别是对极光激酶和 CDK 的双重抑制活性，适用于细胞增殖性疾病，如癌症。
• US7879887B2
  申请人：——

  公开号：US7879887B2

  公开（公告）日：2011-02-01